Phase I trial of the PARP inhibitor veliparib (V) in combination with carboplatin (C) in metastatic breast cancer (MBC).
Robert Wesolowski
No relevant relationships to disclose
Meng Zhao
No relevant relationships to disclose
Susan Michelle Geyer
No relevant relationships to disclose
Maryam B. Lustberg
No relevant relationships to disclose
Ewa Mrozek
No relevant relationships to disclose
Rachel M. Layman
No relevant relationships to disclose
Erin Macrae Macrae
No relevant relationships to disclose
Jun Zhang
No relevant relationships to disclose
Nathan Hall
No relevant relationships to disclose
Katharina Schregel
No relevant relationships to disclose
Susan Ottman
No relevant relationships to disclose
Andrea Camp
No relevant relationships to disclose
Jeffrey J. Chalmers
No relevant relationships to disclose
Eleni Andreopoulou
No relevant relationships to disclose
Miguel Angel Villalona-Calero
No relevant relationships to disclose
Charles L. Shapiro
No relevant relationships to disclose
Michael V. Knopp
No relevant relationships to disclose
Michael R. Grever
No relevant relationships to disclose
Bhuvaneswari Ramaswamy
No relevant relationships to disclose